Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jay I Goodman

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Toxicological Sciences : an Official Journal of the Society of Toxicology|March 30, 2006
Altered methylation in gene-specific and GC-rich regions of DNA is progressive and nonrandom during promotion of skin tumorigenesisAmmie N Bachman, Geoffrey M Curtin, David J Doolittle, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|April 23, 2004
The value of DNA methylation analysis in basic, initial toxicity assessmentsRebecca E Watson, James M McKim, Gary L Cockerell, et al.
Archives of Toxicology|August 13, 2014
Re: Waalkes et al.: Lung tumors in mice induced by "whole-life" inorganic arsenic exposure at human-relevant doses, Arch Toxicol, 2014Samuel M Cohen, Lora L Arnold, James E Klaunig, et al.
Toxicology and Applied Pharmacology|April 20, 2004
Epigenetics and cancer: implications for drug discovery and safety assessmentJonathan G Moggs, Jay I Goodman, James E Trosko, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|December 19, 2006
Orphan nuclear receptor constitutive active/androstane receptor-mediated alterations in DNA methylation during phenobarbital promotion of liver tumorigenesisJennifer M Phillips, Yukio Yamamoto, Masahiko Negishi, et al.
Toxicology|March 29, 2014
Phenobarbital and propiconazole toxicogenomic profiles in mice show major similarities consistent with the key role that constitutive androstane receptor (CAR) activation plays in their mode of actionRichard A Currie, Richard C Peffer, Amber K Goetz, et al.
Molecular Carcinogenesis|September 8, 2004
Increased DNA methylation in the HoxA5 promoter region correlates with decreased expression of the gene during tumor promotionRebecca E Watson, Geoffrey M Curtin, Gary M Hellmann, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 25, 2007
A review of large granular lymphocytic leukemia in Fischer 344 rats as an initial step toward evaluating the implication of the endpoint to human cancer risk assessmentJohnson Thomas, Joseph K Haseman, Jay I Goodman, et al.
Nucleic Acids Research|January 28, 2014
Computational modeling identifies key gene regulatory interactions underlying phenobarbital-mediated tumor promotionRaphaëlle Luisier, Elif B Unterberger, Jay I Goodman, et al.
Environmental and Molecular Mutagenesis|February 14, 2012
Re-evaluation of the Big Blue® mouse assay of propiconazole suggests lack of mutagenicityBarbara S Shane, Errol Zeiger, Walter W Piegorsch, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Toxicological Sciences : an Official Journal of the Society of Toxicology|March 30, 2006
Altered methylation in gene-specific and GC-rich regions of DNA is progressive and nonrandom during promotion of skin tumorigenesisAmmie N Bachman, Geoffrey M Curtin, David J Doolittle, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|April 23, 2004
The value of DNA methylation analysis in basic, initial toxicity assessmentsRebecca E Watson, James M McKim, Gary L Cockerell, et al.
Archives of Toxicology|August 13, 2014
Re: Waalkes et al.: Lung tumors in mice induced by "whole-life" inorganic arsenic exposure at human-relevant doses, Arch Toxicol, 2014Samuel M Cohen, Lora L Arnold, James E Klaunig, et al.
Toxicology and Applied Pharmacology|April 20, 2004
Epigenetics and cancer: implications for drug discovery and safety assessmentJonathan G Moggs, Jay I Goodman, James E Trosko, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|December 19, 2006
Orphan nuclear receptor constitutive active/androstane receptor-mediated alterations in DNA methylation during phenobarbital promotion of liver tumorigenesisJennifer M Phillips, Yukio Yamamoto, Masahiko Negishi, et al.
Toxicology|March 29, 2014
Phenobarbital and propiconazole toxicogenomic profiles in mice show major similarities consistent with the key role that constitutive androstane receptor (CAR) activation plays in their mode of actionRichard A Currie, Richard C Peffer, Amber K Goetz, et al.
Molecular Carcinogenesis|September 8, 2004
Increased DNA methylation in the HoxA5 promoter region correlates with decreased expression of the gene during tumor promotionRebecca E Watson, Geoffrey M Curtin, Gary M Hellmann, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|May 25, 2007
A review of large granular lymphocytic leukemia in Fischer 344 rats as an initial step toward evaluating the implication of the endpoint to human cancer risk assessmentJohnson Thomas, Joseph K Haseman, Jay I Goodman, et al.
Nucleic Acids Research|January 28, 2014
Computational modeling identifies key gene regulatory interactions underlying phenobarbital-mediated tumor promotionRaphaëlle Luisier, Elif B Unterberger, Jay I Goodman, et al.
Environmental and Molecular Mutagenesis|February 14, 2012
Re-evaluation of the Big Blue® mouse assay of propiconazole suggests lack of mutagenicityBarbara S Shane, Errol Zeiger, Walter W Piegorsch, et al.
Pageof 5